Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision label (v3.4.2) replacing the previous (v3.4.1). This appears to be a cosmetic version update.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0; no substantive content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedThe label 'Last Update Posted (Estimated)' in the Study Record Dates section has been replaced with 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor version bump with no changes to visible content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedLocations section updated to reflect changes in trial sites, adding and removing site entries across the U.S. and Canada (California, Illinois, Indiana, Michigan, Pennsylvania, Alberta, Ontario). The revision tag shows v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedPublications section now notes that items are automatically filled from PubMed. The revision version is updated to v3.3.2, replacing the previous PubMed description (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.